Literature DB >> 9506660

Delayed-onset profound biotinidase deficiency.

B Wolf1, R J Pomponio, K J Norrgard, I T Lott, E R Baumgartner, T Suormala, V T Ramaekers, T Coskun, A Tokatli, I Ozalp, J Hymes.   

Abstract

Children with biotinidase deficiency usually exhibit symptoms at several months to years of age. We describe four children who had symptoms later in childhood or during adolescence; they had motor limb weakness, spastic paresis, and eye problems, such as loss of visual acuity and scotomata, rather than the more characteristic symptoms observed in young untreated children with the disorder. These older children each have different mutations, but they are the same as those of children who have exhibited symptoms at an early age. Biotinidase deficiency should be considered in older children who suddenly experience limb weakness and/or spastic paresis and eye symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506660     DOI: 10.1016/s0022-3476(98)70464-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

1.  Children with profound biotinidase deficiency should be treated with biotin regardless of their residual enzyme activity or genotype.

Authors:  Barry Wolf
Journal:  Eur J Pediatr       Date:  2002-03       Impact factor: 3.183

2.  Celiac Disease Presenting with Biotinidase Deficiency and Paraplegia.

Authors:  Sahin Erdol; Halil Saglam; Tanju Ozkan Basarır; Mehmet Sait Okan
Journal:  Indian J Pediatr       Date:  2016-02-02       Impact factor: 1.967

3.  Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases.

Authors:  T Baykal; G Gokcay; Y Gokdemir; F Demir; Y Seckin; M Demirkol; K Jensen; B Wolf
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Novel imaging findings in two cases of biotinidase deficiency-a treatable metabolic disorder.

Authors:  Maya Dattatraya Bhat; P S Bindu; Rita Christopher; Chandrajit Prasad; Abha Verma
Journal:  Metab Brain Dis       Date:  2015-06-04       Impact factor: 3.584

5.  Development and characterization of a mouse with profound biotinidase deficiency: a biotin-responsive neurocutaneous disorder.

Authors:  Kirit Pindolia; Megan Jordan; Caiying Guo; Nell Matthews; Donald M Mock; Erin Strovel; Miriam Blitzer; Barry Wolf
Journal:  Mol Genet Metab       Date:  2010-10-13       Impact factor: 4.797

6.  Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening.

Authors:  Mehmet Karaca; Rıza Köksal Özgül; Özlem Ünal; Didem Yücel-Yılmaz; Mustafa Kılıç; Burcu Hişmi; Ayşegül Tokatlı; Turgay Coşkun; Ali Dursun; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2015-03-11       Impact factor: 3.183

7.  "Think metabolic" in adults with diagnostic challenges: Biotinidase deficiency as a paradigm disorder.

Authors:  Barry Wolf
Journal:  Neurol Clin Pract       Date:  2017-12

8.  Irreversibility of Symptoms with Biotin Therapy in an Adult with Profound Biotinidase Deficiency.

Authors:  Patrick Ferreira; Alicia Chan; Barry Wolf
Journal:  JIMD Rep       Date:  2017-02-21

Review 9.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach.

Authors:  F Sedel; B Fontaine; J M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

10.  Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients.

Authors:  Shrinivas Desai; Karthik Ganesan; Anaita Hegde
Journal:  Pediatr Radiol       Date:  2008-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.